Latest Asthma Therapeutics Market Research to 2020 - Personalized Treatment for Severe Asthma to Drive Market Growth despite Patent Expirations

The research report identifies the key driving factors of the asthma therapeutics market as the rising environmental pollution that adversely affects the respiratory system of the human body, causing asthma and other respiratory diseases. Rapidly growing industrialization and globalization have led to an imbalance in the environmental constitution.

One of the most conspicuous trends in this market is the adoption of a combination of therapies for the treatment of asthma patients. This technique can further help asthma patients by controlling inflammation caused in the respiratory tract. However, the biggest challenge faced by the drug producers is the etiology of respiratory diseases owing to which developing the remedy becomes a tough job.

Browse Full Report With TOC: http://www.mrrse.com/reports/asthma-therapeutics-market

Some of the key players of the global asthma therapeutics market are GlaxoSmithKline plc, Merck & Co. Inc., Novartis AG, AstraZeneca plc, and F. Hoffmann-La Roche Ltd. GlaxoSmithKline plc (GSK) is the topmost seller of drugs of the of the global asthma therapeutics market. The British multinational company which was formed in 2000 is the largest drug and vaccine manufacturer for major diseases such as infections, digestive, asthma, mental health conditions, diabetes, and cancer.
Advair – an eminent asthma therapeutic product is the highly selling drug which is manufactured by GlaxoSmithKline plc. After Advair, the Symbicort drug manufactured by AstraZeneca holds the second position in selling asthma drugs in the global asthma therapeutics market.

The global market for asthma therapeutics is expecting substantial growth in the near future amongst the eight leading developed economies. The global predominance of asthma is increasing everyday which is expected to affect millions of people across the globe. As per figures provided by WHO, in 2011 around 23 million globally people were affected by asthma and the number of asthma patients is expected to increase in the near future.

In 2013, the global market for asthma therapeutics stood at US$18.4 billion and is anticipated to touch US$21.7 billion by the end of 2020 exhibiting a progressive 2.4% CAGR through the forecast period. The revenue figures are rising despite the generic erosion that is faced by many key asthma drug brands such as Symbicort (budesonide/formoterol fumarate), Xolair (omalizumab), and Advair (fluticasone propionate/salmeterol xinafoate). Another reason for the increasing demand in asthma therapeutics market is an influx of new entrants in the global market and the rising number of respiratory diseases.

Request Send An Enquiry: http://www.mrrse.com/enquiry/asthma-therapeutics-market

The majority of asthma patients address their symptoms by using readily available marketed products; however some of the patients are not able to cure asthma with the same type of medications. This undesired difference can be leveled by the industry players in the near future.
A highly effective and innovative asthma pipeline has received a positive response from the industry. This pipeline includes a set of molecules in the later stage of drug development process. In the pharmaceuticals sector, drug pipeline comprises the drugs that the company is developing. Monoclonal antibodies and biologics are gaining importance within the indication.
Some of the novel monoclonal antibodies such as reslizumab, lebrikizumab, dupilumab target interleukins (IL), or IL receptors, and mepolizumab, have proven their potential in severe and inadequately controlled eosinophilic asthma, for which more patients are in need of personalized therapy.


About Us:

MRRSE stands for Market Research Reports Search Engine, the largest online catalog of latest market research reports based on industries, companies, and countries. MRRSE sources thousands of industry reports, market statistics, and company profiles from trusted entities and makes them available at a click. Besides well-known private publishers, the reports featured on MRRSE typically come from national statistics agencies, investment agencies, leading media houses, trade unions, governments, and embassies.

MRRSE’s interface is tailored to provide all possible information about a market research report via a simple, snappy layout. Our refined algorithm returns specific results from hundreds of thousands of reports that lie in our database. Users can search for market research reports according to industries, sub-industries, company names or countries.

Contact Us:
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030

Email: sales@mrrse.com
Website: http://www.mrrse.com/

Comments

Popular posts from this blog

New reports Acetone Market Global Industry Analysis and Opportunity Assessment, 2014 – 2020

Global Industrial Logistics Robots Market Shares, Status, Opportunities, Market Forecasts, 2014 to 2020

Global Insulation (Fiberglass, Plastic Foam, Mineral Wool and Others) Market Residential Construction, Industrial Trends and Forecast 2014 – 2020